Articles & Resources

Insights

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Filter insights

Critical Steps for Successful POC Consumable Production Scale-Up

How to plan for automation and scale-up throughout the design process to enable seamless transfer to manufacturing.

Strategies to Lower Point of Care Device Costs

5 ways design and manufacturing teams can work together to design for manufacturability and develop lower cost Point of Care diagnostic devices.

Emergency Use Authorization: How IVD Developers Can Use the EUA to Address COVID-19

Watch our interview with Fran White of MDC Associates on using the EUA for COVID-19 testing to fast track approval, what’s required by the FDA and how to plan for an eventual 510(k).

Detecting Coronavirus at the Point of Care – In Search of Bold Breakthroughs

In the fight against the Coronavirus pandemic, rapid detection of the disease is key. Point of Care diagnostics can rise to the challenge by providing accelerated time to result at the point of need.

Got Approval… Now What? Meeting Cell Therapy Market Demand

Panelists from bluebird bio, DiscGenics and Proteus, LLC share their vision for commercial manufacturing of cell therapies.

Drivers for Utilizing Cloud Solutions in POCT Device Development

Leveraging cloud solutions for Point of Care (POC) devices can significantly reduce development time and instrument cost while adding more diagnostic capabilities.

11 Ways to Reduce POC Consumable Costs

GUIDE: Best Practices for Point of Care Product Development

Download this guide to learn how to accelerate timelines, minimize risk and maximize commercial success.

Essential Design Principles to Develop CLIA Waived Devices

Making a complex test easy for end users is an interesting challenge and diagnostic device manufacturers must embrace good design principles to get it done.

Navigating the Cost and Time of Cell Therapy Manufacturing Process Automation

In this article, we discuss available devices and technology developments for cell therapy products in preclinical, clinical and early commercialization phases.

Avoiding the Potholes Along the Pathway to Commercial Cell Therapies

Panelists from Cell Therapies, Duke University and Fate Therapeutics discuss how they envision the road ahead for some of the biggest challenges in cell therapy manufacturing.

How Strategic Program Management Can Foster Innovation for IVD Companies

In an interview with MedCity News, Gerald Kent discusses how in vitro diagnostic (IVD) companies can foster innovation and create value through strategic program management.